Parenteral Drugs (India) (NSE:PDPL) Total Liabilities: ₹13,081.42 Mil (As of Mar. 2022)


NSE:PDPL Parenteral Drugs (India) Ltd NSE:PDPL
4 GF Score
Price ₹2.90
View Full Analysis

What is Parenteral Drugs (India) Total Liabilities?

Parenteral Drugs (India) NSE:PDPL 4 Total Liabilities is ₹13,081.42 Mil as of Mar. 2022. GuruFocus rates NSE:PDPL with a GF Score™ of 4/100.

Parenteral Drugs (India)'s Total Liabilities for the quarter that ended in Mar. 2022 was ₹13,081.42 Mil.

Parenteral Drugs (India)'s quarterly Total Liabilities declined from Sep. 2021 (₹13,257.00 Mil) to Dec. 2021 (₹0.00 Mil) but then increased from Dec. 2021 (₹0.00 Mil) to Mar. 2022 (₹13,081.42 Mil).

Parenteral Drugs (India)'s annual Total Liabilities increased from Mar. 2020 (₹11,130.34 Mil) to Mar. 2021 (₹12,509.58 Mil) and increased from Mar. 2021 (₹12,509.58 Mil) to Mar. 2022 (₹13,081.42 Mil).

Parenteral Drugs (India) Total Liabilities Historical Data

* Premium members only.

The historical data trend for Parenteral Drugs (India)'s Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Parenteral Drugs (India) Total Liabilities Chart

Parenteral Drugs (India) Annual Data
Trend Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10,265.76 9,873.68 11,130.34 12,509.58 13,081.42

Parenteral Drugs (India) Quarterly Data
Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12,509.58 0.00 13,257.00 0.00 13,081.42
NSE:PDPL
4GF Score
Parenteral Drugs (India) Ltd NSE:PDPL
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Parenteral Drugs (India) Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Parenteral Drugs (India)'s Total Liabilities for the fiscal year that ended in Mar. 2022 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=12008.375+(1071.994+1.05
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=13,081.42

Total Liabilities=Total Assets (A: Mar. 2022 )-Total Equity (A: Mar. 2022 )
=4842.338--8239.081
=13,081.42

Parenteral Drugs (India)'s Total Liabilities for the quarter that ended in Mar. 2022 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=12008.375+(1071.994+1.05
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=13,081.42

Total Liabilities=Total Assets (Q: Mar. 2022 )-Total Equity (Q: Mar. 2022 )
=4842.338--8239.081
=13,081.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of ₹13,081.42 Mil mean?
Parenteral Drugs (India) (NSE:PDPL) has a Total Liabilities of ₹13,081.42 Mil as of Mar. 2022. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Parenteral Drugs (India) and its competitors.
Is Parenteral Drugs (India)'s Total Liabilities too high?
Parenteral Drugs (India)'s current Total Liabilities is ₹13,081.42 Mil. Overall, Parenteral Drugs (India) has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Parenteral Drugs (India)'s Total Liabilities compare to ZTS and CTLT?
Parenteral Drugs (India)'s Total Liabilities of ₹13,081.42 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Drug Manufacturers company?
A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Parenteral Drugs (India) and its competitors. Parenteral Drugs (India)'s current Total Liabilities is ₹13,081.42 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Parenteral Drugs (India) stock overvalued right now?
Parenteral Drugs (India) (NSE:PDPL) has a current Total Liabilities of ₹13,081.42 Mil. The current Total Liabilities is ₹13,081.42 Mil. Parenteral Drugs (India)'s overall GF Score™ is 4/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Parenteral Drugs (India) (NSE:PDPL), the current Total Liabilities is ₹13,081.42 Mil as of Mar. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Parenteral Drugs (India) Business Description

Address Navlakha Crossing, A. B. Road, Shree Ganesh Chambers, Indore, MP, IND, 452001
Parenteral Drugs (India) Ltd is a pharmaceutical company. It is principally engaged in manufacturing pharmaceutical preparations. The company manufactures products in categories like intravenous (IV) fluids, oncology, anesthesia, and export products. Its IV fluids products include carbohydrates and electrolytes, diuretics, dialysis, and irrigation solution, anti-infective and anti-fungal, and other pharmaceutical products.
4GF Score

Get the complete analysis for NSE:PDPL

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹2.90
Price